Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2020-04-01
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CAVE
10 immersive virtual reality sessions to train spatial memory
CAVE
The training is designed to train spatial navigation and memory and in particular egocentric and allocentric processes
TAU
10 paper and pencil sessions to train spatial memory
TAU
This is the usual care used to train visuospatial processes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAVE
The training is designed to train spatial navigation and memory and in particular egocentric and allocentric processes
TAU
This is the usual care used to train visuospatial processes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* absence of severe cognitive deterioration as assessed by the Italian version of the MMSE (Magni et al. 1996)
* age ≥ 60
Exclusion Criteria
* the presence of other concomitants severe neurological/psychiatric diseases;
* history of traumatic brain injury with loss of consciousness;
* physical/functional deficits that could affect the use of immersive virtual reality;
* severe visual deficiency;
* the presence of recurrent vertigo.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Auxologico Italiano
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cosimo Tuena
Milan, Lombardy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
39M801
Identifier Type: -
Identifier Source: org_study_id